| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC4141 | |||||||||||||||||||||||
| Submitter : | Mr. DONALD KALCIK | Date & Time: | 12/22/2006 11:12:43 | |||||||||||||||||||||
| Organization : | Mr. DONALD KALCIK | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I want to strongly urge revision of the guidelines to explicitly prohibit the use of tissue from directly aborted fetuses and destroyed embryos in the future, in the development of vaccines to be approved by th FDA. I also urge the FDA to encourge and approve the development of cell lines not derived from tissue taken from directly aborted fetuses and the approval of the importation of save vaccines which have been manufactured without using cell lines from aborted fetuses or destroyed embroyos. | ||||||||||||||||||||||||